Pamela Morris to Treatment Outcome
This is a "connection" page, showing publications Pamela Morris has written about Treatment Outcome.
Connection Strength
0.073
-
Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. J Am Coll Cardiol. 2019 10 15; 74(15):1926-1942.
Score: 0.018
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.017
-
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004652.
Score: 0.017
-
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
Score: 0.015
-
Gender differences in left ventricular functional response to aortic valve replacement. Circulation. 1994 Nov; 90(5 Pt 2):II183-9.
Score: 0.003
-
Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991 Nov; 84(5 Suppl):III275-84.
Score: 0.003